|
Volumn 33, Issue 7-8, 2001, Pages 3568-3571
|
Heart-lung-liver transplant for cystic fibrosis
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ACICLOVIR;
AMPHOTERICIN B;
AZATHIOPRINE;
CEFTAZIDIME;
CYCLOSPORIN;
GABAPENTIN;
LEVOFLOXACIN;
MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;
PREDNISONE;
PROPRANOLOL;
RAPAMYCIN;
TACROLIMUS;
THYMOCYTE ANTIBODY;
VANCOMYCIN;
ARTICLE;
CASE REPORT;
CYSTIC FIBROSIS;
DISEASE ASSOCIATION;
DISEASE COURSE;
ESOPHAGUS VARICES;
GRAFT REJECTION;
HEART LUNG TRANSPLANTATION;
HUMAN;
IMMUNOSUPPRESSIVE TREATMENT;
LIVER TRANSPLANTATION;
MALE;
ORGAN DONOR;
POSTOPERATIVE COMPLICATION;
PRIORITY JOURNAL;
STOMACH VARICES;
TREATMENT OUTCOME;
ADOLESCENT;
CYSTIC FIBROSIS;
FATAL OUTCOME;
HEART-LUNG TRANSPLANTATION;
HUMANS;
LIVER TRANSPLANTATION;
LUNG;
MALE;
|
EID: 0035671401
PISSN: 00411345
EISSN: None
Source Type: Journal
DOI: 10.1016/S0041-1345(01)02537-4 Document Type: Article |
Times cited : (16)
|
References (14)
|